NSEIX Nicholas Equity Income I Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), JPMorgan Chase & Co (NYSE:JPM), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Merck & Co (NYSE:MRK), Charles Schwab Corp (The) (NYSE:SCHW), TJX Companies (NYSE:TJX), Medtronic plc (NYSE:MDT).

The investment seeks to produce reasonable income and the fund's secondary goal is moderate long-term growth. To achieve moderate long-term growth, the fund seeks a five-year return which approximates three-fourths of the average total return achieved over a five-year period on the S&P 500 Index. It invests in a diversified portfolio of income-producing equity securities (including common stocks, preferred stocks and convertible securities) and corporate and government fixed income investments (including notes, bonds and debentures). The fund invests, under normal market conditions, at least 80% of its net assets in equity securities.

The average market capitalization across the Nicholas Equity Income I MF is 593.25B. The market cap for tickers in the group ranges from 13.67B to 3.77T. MSFT holds the highest valuation in this group at 3.77T. The lowest valued company is LECO at 13.67B.

The average weekly volume growth across all stocks in the Nicholas Equity Income I MF was -37%. For the same stocks of the MF, the average monthly volume growth was -11% and the average quarterly volume growth was -47%